Novel markers for Alzheimer’s disease monitoring and prognostication

In this episode, our expert guests will discuss their work on the discovery and validation of promising new biomarkers for monitoring, prognostication, and clinical trial outcomes. Novel markers beyond the classical measures of plasma amyloid and phosphorylated tau will be discussed, including TREM2, neurofilament light, retinal imaging, and blood-brain barrier leakage.